|Bid||123.00 x 800|
|Ask||129.00 x 900|
|Day's Range||123.60 - 128.17|
|52 Week Range||50.00 - 140.00|
|Beta (5Y Monthly)||1.71|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 05, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Sep 26, 2012|
|1y Target Est||141.00|
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson, Heska's President & Chief Executive Officer, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference on Tuesday, December 1, 2020.
Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, appointed Robert L. Antin, the Founder of VCA Antech, Inc., to the Company's Board of Directors (the "Board"), effective November 17, 2020.
Prior to discussing Heska's third quarter 2020 results, I would like to remind you that during the course of this call, we may make certain forward-looking statements regarding future events or future financial performance of the company. Factors that could contribute to such differences are detailed in writing in this morning's earnings release or in Heska Corporation's annual and quarterly filings with the SEC and elsewhere. Any forward-looking statements speak only as the time they are made, and Heska does not intend and specifically disclaims any obligation or intention to update any forward-looking statement to reflect events that occur, after the time such statement was made.